Spotlight on CDER Science

Spotlight on CDER Science

Lab Tests in Rodents Suggest Potential New Biomarker for Acute Pancreatic Injury

Rodney Rouse, DVM, MBA, PhD, Research Veterinary Medical Officer and Acting Associate Director, Division of Applied Regulatory Science, Office of Translational Sciences, Center for Drug Evaluation and Research

Biomarkers are measurable indicators in the body that can signify the presence of disease or disease severity.  The identification of new, reliable and sensitive biomarkers remains a priority for the FDA.   In addition to measuring disease presence and severity, a biomarker may detect early tissue injury caused by a drug. These types of biomarkers may be used in safety studies to better characterize a drug’s risk profile during drug development.

More with Rodney Rouse, DVM, MBA, PhD

Page Last Updated: 06/30/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English